Clinical Study

Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery

Figure 1

(a)–(d) Patient 4: (a) slit lamp photograph showing refractile fine granular opacities of the anterior IOL surface; (b) explanted bisected IOL; (c) high power photomicrograph (unstained) showing granular infiltration beneath anterior IOL surface; (d) positive staining with alizarin red (OM ×100). (IOL: intraocular lens; OM: original magnification).
(a)
(b)
(c)
(d)